Specimen transport market seen reaching $3.94 billion by 2030

The specimen transport solutions market is projected to nearly double by 2030 as diagnostic testing, cold chain logistics and digital tracking gain traction worldwide. North America leads today, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Specimen transport is becoming more central to healthcare as test volumes rise and labs need better sample integrity, traceability and temperature control. - The market’s growth points to broader demand for diagnostics, biobanking, clinical research and outsourced lab services.

What happened: - The specimen transport solutions market is forecast to grow from $2.43 billion in 2025 to $2.67 billion in 2026, a 9.9% compound annual growth rate. - The Business Research Company projects the market will reach $3.94 billion by 2030, growing at a 10.2% annual rate. - The report was published from London on July 22, 2026. - A free sample of the market report is available. - The full specimen transport solutions market report is also available.

The details: - Specimen transport solutions cover the methods, technologies and systems used to move biological samples from collection sites to testing labs. - The systems are designed to preserve sample integrity, stability and traceability during transit. - The report links recent growth to weak standardization in sample transport, stronger demand for reliable diagnostic testing, expansion of clinical lab networks, greater awareness of contamination risks and early adoption of cold chain logistics. - The report says future growth will be supported by demand for precise diagnostics and personalized medicine, broader use of digital tracking and IoT monitoring, biobanking growth, clinical research expansion, outsourcing of lab testing and automated temperature-controlled logistics. - Key trends identified in the report include temperature-regulated transport systems, IoT-enabled real-time tracking, tamper-proof and traceable packaging, cold chain logistics for biological materials and automated specimen transfer between laboratories. - The report says increasing diagnostic testing is a major driver because specimen transport helps keep clinical samples secure and within proper temperature ranges before analysis. - England recorded 45.0 million imaging tests in the year ending March 2023, up 2.2% from the prior year, according to the UK National Health Service in November 2023. - That NHS data included 10.3 million diagnostic ultrasounds, 7.1 million CT scans and 4.1 million MRI scans. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region over the coming years. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market outlook suggests healthcare operators are treating sample transport as a quality and compliance issue, not just a logistics task. - Faster adoption of tracking, automation and cold chain tools signals a push to reduce handling errors and protect test accuracy as diagnostic volumes climb.

What's next: - The report expects continued demand from precision medicine, research workflows and outsourced testing. - Adoption of monitored, temperature-controlled and traceable transport systems is likely to deepen as labs look to reduce risk and improve turnaround times. - The Business Research Company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel forecasting dashboards, market hotspots infographics and updated graphics and tables.